Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -126.26%-44.75M | 54.15%-20.31M | -30.07%-38.23M | -683.77%-108.43M | -14.96M | -19.78M | -44.3M | -29.39M | -146.02%-13.83M | 153.72%30.06M |
| Net profit before non-cash adjustment | 521.56%7.09M | 318.23%3.6M | 317.24%2.54M | -51.11%8.46M | --8.36M | --1.14M | ---1.65M | --609K | 23.70%17.3M | -27.89%13.99M |
| Total adjustment of non-cash items | 48.73%4.51M | 158.80%4.97M | 95.64%3.99M | 204.00%10.4M | --3.41M | --3.04M | --1.92M | --2.04M | 9.30%3.42M | -0.05%3.13M |
| -Depreciation and amortization | -152.08%-175K | 77.15%946K | -26.68%338K | -2.10%1.33M | --2.19K | --336K | --534K | --461K | -12.29%1.36M | 0.27%1.55M |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | --193.99K | ---- | ---- | ---- | ---- | --0 | --30K |
| -Disposal profit | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -32.60%-66.3K | 50.00%-50K |
| -Other non-cash items | 73.18%4.67M | 191.34%4.04M | 131.33%3.66M | 317.40%8.87M | --3.21M | --2.7M | --1.39M | --1.58M | 33.05%2.13M | -5.09%1.6M |
| Changes in working capital | -135.26%-56.36M | 35.19%-28.88M | -39.70%-44.76M | -268.34%-127.29M | ---26.73M | ---23.95M | ---44.57M | ---32.04M | -366.91%-34.56M | 221.24%12.95M |
| -Change in receivables | -61.13%-34.77M | 109.50%4.72M | -149.52%-25.88M | -4,869.68%-54.61M | --27M | ---21.58M | ---49.66M | ---10.37M | 114.71%1.14M | -440.25%-7.78M |
| -Change in inventory | -33.31%-36.8M | -38.90%-21.13M | -73.61%-9.72M | -107.26%-98.96M | ---50.54M | ---27.6M | ---15.22M | ---5.6M | -375.80%-47.75M | -189.22%-10.03M |
| -Change in payables | -39.69%15.22M | -161.40%-12.47M | 42.99%-9.16M | 432.20%85.38M | --55.91M | --25.23M | --20.31M | ---16.07M | 1,244.06%16.04M | 169.72%1.19M |
| -Changes in other current assets | ---- | ---- | ---- | -1,377.81%-59.1M | ---- | ---- | ---- | ---- | -113.52%-4M | 479.84%29.57M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -37.17%-5.51M | 129.07%1.65M | -459.80%-9.97M | -245.03%-10.59M | 866.73K | -4.01M | -5.66M | -1.78M | -36.59%-3.07M | -6.89%-2.25M |
| Interest received (cash flow from operating activities) | -53.82%145K | 61.59%265K | 68.16%338K | 1.34%961.84K | 282.84K | 314K | 164K | 201K | 50.07%949.14K | 51.00%632.48K |
| Tax refund paid | 40.72%-1.67M | -48.68%-959K | -56.60%-1.47M | -41.95%-5.77M | -1.36M | -2.82M | -645K | -940K | -23.77%-4.06M | 8.16%-3.28M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -96.88%-51.78M | 61.62%-19.36M | -54.59%-49.33M | -518.62%-123.82M | ---15.17M | ---26.3M | ---50.44M | ---31.91M | -179.53%-20.02M | 281.74%25.17M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 27.77%-24.51M | -112.24%-9.33M | -377.37%-14.43M | -125.29%-61M | ---19.64M | ---33.94M | ---4.4M | ---3.02M | -91.17%-27.08M | -738.34%-14.16M |
| Net investment property transactions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --0 |
| Net investment product transactions | ---- | 667.69%13.8M | -173.32%-12.6M | -139,935.41%-5.77M | ---- | ---- | --1.8M | ---4.61M | -98.83%4.13K | 195.08%352.91K |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --64K |
| Investing cash flow | 17.39%-25.71M | 272.31%4.48M | -254.13%-27.03M | -146.63%-66.77M | ---25.41M | ---31.13M | ---2.6M | ---7.63M | -96.94%-27.07M | -567.10%-13.75M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 7.77%45.46M | -30.41%23.71M | 63.75%68.36M | 323.91%175.5M | --57.5M | --42.18M | --34.08M | --41.74M | 403.81%41.4M | -137.86%-13.63M |
| Net common stock issuance | --0 | ---- | ---- | --46.04M | ---662.44K | --0 | ---- | ---- | --0 | ---- |
| Increase or decrease of lease financing | 73.96%-187K | 157.26%560K | -415.14%-953K | -43.79%-2.65M | ---764.77K | ---718K | ---978K | ---185K | -86.51%-1.84M | 23.04%-986.52K |
| Cash dividends paid | --0 | --0 | 84.00%-2.4M | 0.00%-15M | --0 | --0 | --0 | ---15M | ---15M | ---- |
| Net other fund-raising expenses | 2,821.54%16.3M | 14.10%1.53M | -12.06%-762K | 130.41%583.79K | --522.79K | ---599K | --1.34M | ---680K | 43.49%-1.92M | -94.37%-3.4M |
| Financing cash flow | 50.68%61.57M | -68.20%25.8M | 148.25%64.24M | 803.15%204.48M | --56.6M | --40.86M | --81.14M | --25.88M | 225.70%22.64M | -154.64%-18.01M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.16%32.38M | 255.32%21.47M | 70.44%33.59M | -55.37%19.71M | --17.58M | --34.14M | --6.04M | --19.71M | -12.98%44.16M | 283.01%50.75M |
| Current changes in cash | 3.86%-15.93M | -61.15%10.92M | 11.27%-12.13M | 156.79%13.88M | --16.02M | ---16.57M | --28.1M | ---13.67M | -271.05%-24.45M | -117.57%-6.59M |
| End cash Position | -6.38%16.46M | -5.16%32.38M | 255.32%21.47M | 70.44%33.59M | --33.59M | --17.58M | --34.14M | --6.04M | -55.37%19.71M | -12.98%44.16M |
| Free cash flow | -27.91%-77.12M | 47.66%-28.7M | -82.52%-63.77M | -291.87%-184.82M | ---34.77M | ---60.29M | ---54.84M | ---34.94M | -530.53%-47.16M | 128.05%10.95M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.